
River Birch Research Alliance, LLC was established in 1992 by
Dr. Raymond E. Tidman, MD. Our company collaborates with leading
companies of the pharmaceutical industry in the investigation of
new drugs and medications through clinical trials studies.
Over the years, River Birch Research has developed a reputation
of excellence and trust by exceeding all enrollment goals and by
completing the highest quality of work in investigational medical
studies in the areas of: cardiovascular, gastroenterology,
endocrinology, musculoskeletal, infectious diseases, rheumatology
and dermatology. In particular, River Birch Research is a magnet
for studies in COPD, osteoporosis, rheumatoid and osteoarthritis,
pain and chronic pain management, bronchitis, pneumonia,
hypertension, hyperlipidemia, and skin infections.
With the expansion of our physician team, we aim to bring new
studies that benefit our growing patient community in areas of
women%92s health, sports medicine, depression and anxiety, and
hormone deficiencies.
Located "on the hill" at Riverstone Medical Campus --
a multi-specialty group clinic -- off GA 515
(www.riverstonemd.com),
our success is driven primarily by the quality of care offered to
our patients by our physicians, clinical and nursing staff. We
welcome you to come and visit us, and learn with us, as we strive
to bring better health to the greater north Georgia community.
Therapeutic areas:
- COPD
- Asthma
- Obesity
- Diabetes
- Osteoporosis
- Osteo- and rheumatoid arthritis
- Pneumonia
- Bronchitis (acute, chronic)
- Hypertension
- Hyperlipid
- Depression
- Anxiety
- Hormone deficiency
- Psoriasis
- Skin infections
- Other infectious diseases
CROs:
Quintiles, ICON, Innovex, PPD, iNC Research, Paragon, Sanofi,
Ingenix Pharm, Scirex, Parexel, Omnicare, Global, etc...
For list of sponsors and years of
experience:
| Indication |
Sponsor |
Drug |
Year |
| Pneumonia |
Rhone-Poulenc Rorer |
Sparfloxacin |
1994 |
| Chronic Bronchitis |
Rhone-Poulenc Rorer |
Sparfloxacin |
1994 |
| Hypertension with LVH |
Merck & Co. |
Losartan |
1994 |
| Hypertension |
Sanko |
Tempocapril HCL |
1994 |
| Chronic Bronchitis |
Rhone-Poulenc Rorer |
Sparfloxacin |
1996 |
| Pneumonia |
Rhone-Poulenc Rorer |
Sparfloxacin |
1996 |
| COPD |
Dey Labs |
Ipratropium |
1996 |
| H-Pylori |
Astra+Merck |
Omeprazole |
1996 |
| Hypertension |
Bristol-Myers |
Irbesartan |
1997 |
| COPD |
SmithKline |
SB207499 |
1997 |
| Heartburn |
TAP Holdings, Inc. |
Lansoprazole |
1997 |
| Summer Flu |
ViroPharma |
Pleconaril |
1997 |
| Type II Diabetes |
SmithKline |
BRL49653C |
1997 |
| Dyspepsia |
TAP Holdings, Inc. |
Lansoprazole |
1997 |
| Post-MI |
Proctor & Gamble |
Azimilide |
1997 |
| GERD |
TAP Holdings, Inc. |
EM574 |
1997 |
| Catheter-related Bacteremia |
Rhone-Poulenc Rorer |
Synercid |
1997 |
| Chronic Bronchitis |
TAP Holdings, Inc. |
Cefditoren |
1998 |
| Summer Flu |
ViroPharma |
Pleconaril |
1998 |
| COPD |
SmithKline |
Ariflo |
1998 |
| Pneumonia |
TAP Holdings, Inc. |
Cefditoren |
1998 |
| Chronic Bronchitis |
SmithKline |
SB265805 |
1999 |
| Pneumonia |
SmithKline |
SB265805 |
1999 |
| Chronic Bronchitis |
Bristol-Myers |
Cefprozil |
1999 |
| COPD |
Glaxo Wellcome |
Salmeterol |
1999 |
| COPD |
Pfizer |
CJ-13,610 |
1999 |
| Pneumonia |
Abbott |
ABT-773 |
1999 |
| Chronic Bronchitis |
SmithKline |
SB265805 |
1999 |
| Osteoarthritis |
Merck & Co. |
Rofecoxib |
2000 |
| Drug Na%EFve Diabetes |
SmithKline |
Rosiglitazone |
2000 |
| Irritable Bowel Syndrome |
Glaxo Wellcome |
Alosetron |
2000 |
| DNA-Healthy Subjects |
Genomics |
- |
2000 |
| DNA-Diseased Subjects |
Genomics |
- |
2000 |
| In-Patient Pneumonia |
Bayer |
BAY 12-8039 |
2000 |
| Impetigo |
PharmaKinetics |
Mupirocin 2% |
2000 |
| Soft Tissue Infection |
Cubist Pharmaceuticals |
Daptomycin |
2000 |
| Hypertension |
PPD Development |
Omapatrilat |
2000 |
| COPD |
SmithKline |
Ariflo |
2001 |
| Migraine Headache |
Astrazeneca |
- |
2001 |
| Pneumonia |
Bayer |
Faropenem |
2001 |
| Pneumonia |
Cubist Pharmaceuticals, Inc |
Cidecin |
2001 |
| COPD |
SmithKline |
Ariflo |
2001 |
| Sinusitis |
Warner-Lambert |
Sudafed |
2001 |
| Pneumonia |
Aventis |
Telithromycin |
2001 |
| Chronic Bronchitis |
SmithKline |
Augumentin |
2001 |
| Skin+Skin Structure Infection |
Eli Lilly |
Oritavancin |
2001 |
| Irritable Bowel Syndrome |
Solvay |
Celansetron |
2002 |
| COPD |
Abgenix |
ABX-IL8 |
2002 |
| Nursing Home Depression |
Organon |
Remeron |
2002 |
| Asthma |
Aventis |
Ciclesonide |
2002 |
| Pressure Ulcer |
Smith & Nephew |
Santyl |
2002 |
| Sinusitis |
Advanced Biologics |
Levaquin |
2002 |
| Hyperlipidemia |
Sanofi-Synthelabo |
Plavix |
2002 |
| Hypertension |
Bertek |
Nebivolol |
2002 |
| GERD |
PPD Development |
Lansoprazole |
2002 |
| Type II Diabetes |
Astrazeneca |
AZ-242 |
2002 |
| Chronic Bronchitis |
GlaxoSmithKline |
Augmentin SR |
2002 |
| COPD |
GlaxoSmithKline |
Seretide+Viani+Advair |
2002 |
| Rheumatoid Arthritis |
Bristol-Myers Squibb |
BMS-188667 |
2002 |
| Pediatric Pneumonia |
Johnson & Johnson |
Levaquin |
2002 |
| Pediatric Otitis Media |
Johnson & Johnson |
Levaquin |
2002 |
| Laparoscopic Cholecystectomy |
Pharmacia |
Valdecoxib |
2002 |
| Chronic Bronchitis |
Paragon Biomedical |
Clarithromycin ER |
2002 |
| HTN with Hyperlipidemia |
Pfizer |
Amlodipine & Atorvastatin |
2002 |
| Gout |
Pharmacia |
Valdecoxib |
2002 |
| Cardiac Event Prevention |
Astrazeneca |
Avandia |
2002 |
| Type II Diabetes with Insulin |
Parexel |
Avandia |
2002 |
| Hypertension |
Sanofi-Synthelabo |
Avalide |
2003 |
| Migraine Headache |
Pfizer |
Relpax |
2003 |
| Psoriasis |
Genentech, Inc. |
Raptiva |
2003 |
| Type II Diabetes |
GlaxoSmithKline |
Avandia |
2003 |
| COPD |
Centocor |
Remicade |
2003 |
| Irritable Bowel Syndrome |
GlaxoSmithKline |
Lotronex |
2003 |
| Depression |
Eli Lilly |
Duloxetine |
2003 |
| Osteoarthritis of Knee & Hip |
Grunenthal, Inc. |
- |
2004 |
| COPD |
ALTANA Pharma, Inc. |
Roflumilast |
2003 |
| Post-Stroke |
Aventis |
Lovenox |
2003 |
| Chronic Bronchitis |
Abbott |
Biaxin |
2003 |
| Medabolic Syndrome |
Sanofi-Synthelabo |
Plavix |
2003 |
| CAD Prevention |
Astrazeneca |
- |
2003 |
| Hypertension |
Integrium |
Micardis |
2003 |
| Asthma |
PPD Development |
- |
2003 |
| Type II Diabetes |
GlaxoSmithKline |
Avandia |
2003 |
| Migraine Headache |
Access Medical |
Maxalt |
2003 |
| COPD |
Dey Labs |
- |
2004 |
| Benign Prostatic Hypertrophy |
i3 Research |
- |
2004 |
| Skin Infection |
Basilea |
- |
2004 |
| Gout |
Pfizer |
Valdecoxib |
2004 |
| Osteoporosis |
Eli Lilly |
Arzoxifene |
2004 |
| Osteoarthritis |
Alza |
Hydromorphone HCL |
2004 |
| Type II Diabetes |
Takeda |
TAK-559 |
2004 |
| Psoriasis |
Genentech, Inc. |
Raptiva |
2005 |
| Osteoarthritis |
Johnson & Johnson |
CG5503 |
2005 |
| COPD |
Centocor |
Remicade |
2004 |
| Elevated CRP |
PPD Development |
Crestor |
2004 |
| Otitis Media |
Sanofi-Aventis |
Telithromycin |
2005 |
| Metabolic Syndrome |
Bristol-Myers Squibb |
Plavix |
2005 |
| Chronic Bronchitis |
Replidyne, Inc. |
Faropenem |
2005 |
| Hypertension |
Alteon |
Alagebrium |
2005 |
| Type II Diabetes |
Roche |
RO0730699 |
2005 |
| Pneumonia |
Advanced Life Sciences |
Clarithromycin |
2006 |
| COPD |
ALTANA Pharma, Inc. |
Roflumilast |
2006 |
| Hypertension |
Boehringer Ingelheim |
Micardis |
2006 |
| Atrial Fibrillation |
Sanofi-Aventis |
Dronedarone |
2006 |
| Atrial Fibrillation |
Boehringer Ingelheim |
Dabigatran |
2006 |
| Heartburn on NSAIDS |
Pfizer |
Celecoxib |
2006 |
| Heartburn |
PPD |
Prevacid |
2007 |
| Osteoarthritis of Knee & Hip |
Alpharma Pharmaceuticals |
Extended-Release Kadian |
2007 |
| Chronic Pain |
Alpharma Pharmaceuticals |
Extended-Release Kadian |
2007 |
River Birch Research Alliance, LLC is located within the
Riverstone MD PC medical campus. Riverstone MD PC is a
multi-specialty clinic with in house specialty clinic, walk-in
clinic, pharmacy, radiology, dentist, physical therapists, sports
medicine, internal medicine, pediatrics, family practice, oncology,
blood/lab services and arespiratory center. We have specialist
doctors in gastroenterology, podiatry, OB/GYN, ENT, rheumatology,
internal medicine/pediatrics, radiology, oncology, nephrology and
dermatology We are equipped to do X-rays, MRI/CT scans, bone
density, Dexa scans, and many other specialized outpatient
procedures.We are located conveniently off of the Appalachian Hwy
(GA-515) for easy and quick travel for patients. We have a close
partnership with Fannin Regional Hospital which is equipped for
Level III trauma/ER services, as well as Piedmont Mountainside
Hospital in Jasper, GA. For a privately run specialty group clinic,
we boast several high end equipment and services.
)a
Dr. Raymond Tidman, MD
President and CEO, Principal Investigator, Family
Practice
Dr. Kelly Koay, MD
Research Sub-investigator, Internal Medicine and
Pediatrics
Dr. Jack Roof, MD
Research Sub-investigator, Family Practice
Dr. Tidman's research experience:
| Indication |
Sponsor |
Drug |
Year |
| Pneumonia |
Rhone-Poulenc Rorer |
Sparfloxacin |
1994 |
| Chronic Bronchitis |
Rhone-Poulenc Rorer |
Sparfloxacin |
1994 |
| Hypertension with LVH |
Merck & Co. |
Losartan |
1994 |
| Hypertension |
Sanko |
Tempocapril HCL |
1994 |
| Chronic Bronchitis |
Rhone-Poulenc Rorer |
Sparfloxacin |
1996 |
| Pneumonia |
Rhone-Poulenc Rorer |
Sparfloxacin |
1996 |
| COPD |
Dey Labs |
Ipratropium |
1996 |
| H-Pylori |
Astra+Merck |
Omeprazole |
1996 |
| Hypertension |
Bristol-Myers |
Irbesartan |
1997 |
| COPD |
SmithKline |
SB207499 |
1997 |
| Heartburn |
TAP Holdings, Inc. |
Lansoprazole |
1997 |
| Summer Flu |
ViroPharma |
Pleconaril |
1997 |
| Type II Diabetes |
SmithKline |
BRL49653C |
1997 |
| Dyspepsia |
TAP Holdings, Inc. |
Lansoprazole |
1997 |
| Post-MI |
Proctor & Gamble |
Azimilide |
1997 |
| GERD |
TAP Holdings, Inc. |
EM574 |
1997 |
| Catheter-related Bacteremia |
Rhone-Poulenc Rorer |
Synercid |
1997 |
| Chronic Bronchitis |
TAP Holdings, Inc. |
Cefditoren |
1998 |
| Summer Flu |
ViroPharma |
Pleconaril |
1998 |
| COPD |
SmithKline |
Ariflo |
1998 |
| Pneumonia |
TAP Holdings, Inc. |
Cefditoren |
1998 |
| Chronic Bronchitis |
SmithKline |
SB265805 |
1999 |
| Pneumonia |
SmithKline |
SB265805 |
1999 |
| Chronic Bronchitis |
Bristol-Myers |
Cefprozil |
1999 |
| COPD |
Glaxo Wellcome |
Salmeterol |
1999 |
| COPD |
Pfizer |
CJ-13,610 |
1999 |
| Pneumonia |
Abbott |
ABT-773 |
1999 |
| Chronic Bronchitis |
SmithKline |
SB265805 |
1999 |
| Osteoarthritis |
Merck & Co. |
Rofecoxib |
2000 |
| Drug Na%EFve Diabetes |
SmithKline |
Rosiglitazone |
2000 |
| Irritable Bowel Syndrome |
Glaxo Wellcome |
Alosetron |
2000 |
| DNA-Healthy Subjects |
Genomics |
- |
2000 |
| DNA-Diseased Subjects |
Genomics |
- |
2000 |
| In-Patient Pneumonia |
Bayer |
BAY 12-8039 |
2000 |
| Impetigo |
PharmaKinetics |
Mupirocin 2% |
2000 |
| Soft Tissue Infection |
Cubist Pharmaceuticals |
Daptomycin |
2000 |
| Hypertension |
PPD Development |
Omapatrilat |
2000 |
| COPD |
SmithKline |
Ariflo |
2001 |
| Migraine Headache |
Astrazeneca |
- |
2001 |
| Pneumonia |
Bayer |
Faropenem |
2001 |
| Pneumonia |
Cubist Pharmaceuticals, Inc |
Cidecin |
2001 |
| COPD |
SmithKline |
Ariflo |
2001 |
| Sinusitis |
Warner-Lambert |
Sudafed |
2001 |
| Pneumonia |
Aventis |
Telithromycin |
2001 |
| Chronic Bronchitis |
SmithKline |
Augumentin |
2001 |
| Skin+Skin Structure Infection |
Eli Lilly |
Oritavancin |
2001 |
| Irritable Bowel Syndrome |
Solvay |
Celansetron |
2002 |
| COPD |
Abgenix |
ABX-IL8 |
2002 |
| Nursing Home Depression |
Organon |
Remeron |
2002 |
| Asthma |
Aventis |
Ciclesonide |
2002 |
| Pressure Ulcer |
Smith & Nephew |
Santyl |
2002 |
| Sinusitis |
Advanced Biologics |
Levaquin |
2002 |
| Hyperlipidemia |
Sanofi-Synthelabo |
Plavix |
2002 |
| Hypertension |
Bertek |
Nebivolol |
2002 |
| GERD |
PPD Development |
Lansoprazole |
2002 |
| Type II Diabetes |
Astrazeneca |
AZ-242 |
2002 |
| Chronic Bronchitis |
GlaxoSmithKline |
Augmentin SR |
2002 |
| COPD |
GlaxoSmithKline |
Seretide+Viani+Advair |
2002 |
| Rheumatoid Arthritis |
Bristol-Myers Squibb |
BMS-188667 |
2002 |
| Pediatric Pneumonia |
Johnson & Johnson |
Levaquin |
2002 |
| Pediatric Otitis Media |
Johnson & Johnson |
Levaquin |
2002 |
| Laparoscopic Cholecystectomy |
Pharmacia |
Valdecoxib |
2002 |
| Chronic Bronchitis |
Paragon Biomedical |
Clarithromycin ER |
2002 |
| HTN with Hyperlipidemia |
Pfizer |
Amlodipine & Atorvastatin |
2002 |
| Gout |
Pharmacia |
Valdecoxib |
2002 |
| Cardiac Event Prevention |
Astrazeneca |
Avandia |
2002 |
| Type II Diabetes with Insulin |
Parexel |
Avandia |
2002 |
| Hypertension |
Sanofi-Synthelabo |
Avalide |
2003 |
| Migraine Headache |
Pfizer |
Relpax |
2003 |
| Psoriasis |
Genentech, Inc. |
Raptiva |
2003 |
| Type II Diabetes |
GlaxoSmithKline |
Avandia |
2003 |
| COPD |
Centocor |
Remicade |
2003 |
| Irritable Bowel Syndrome |
GlaxoSmithKline |
Lotronex |
2003 |
| Depression |
Eli Lilly |
Duloxetine |
2003 |
| Osteoarthritis of Knee & Hip |
Grunenthal, Inc. |
- |
2004 |
| COPD |
ALTANA Pharma, Inc. |
Roflumilast |
2003 |
| Post-Stroke |
Aventis |
Lovenox |
2003 |
| Chronic Bronchitis |
Abbott |
Biaxin |
2003 |
| Medabolic Syndrome |
Sanofi-Synthelabo |
Plavix |
2003 |
| CAD Prevention |
Astrazeneca |
- |
2003 |
| Hypertension |
Integrium |
Micardis |
2003 |
| Asthma |
PPD Development |
- |
2003 |
| Type II Diabetes |
GlaxoSmithKline |
Avandia |
2003 |
| Migraine Headache |
Access Medical |
Maxalt |
2003 |
| COPD |
Dey Labs |
- |
2004 |
| Benign Prostatic Hypertrophy |
i3 Research |
- |
2004 |
| Skin Infection |
Basilea |
- |
2004 |
| Gout |
Pfizer |
Valdecoxib |
2004 |
| Osteoporosis |
Eli Lilly |
Arzoxifene |
2004 |
| Osteoarthritis |
Alza |
Hydromorphone HCL |
2004 |
| Type II Diabetes |
Takeda |
TAK-559 |
2004 |
| Psoriasis |
Genentech, Inc. |
Raptiva |
2005 |
| Osteoarthritis |
Johnson & Johnson |
CG5503 |
2005 |
| COPD |
Centocor |
Remicade |
2004 |
| Elevated CRP |
PPD Development |
Crestor |
2004 |
| Otitis Media |
Sanofi-Aventis |
Telithromycin |
2005 |
| Metabolic Syndrome |
Bristol-Myers Squibb |
Plavix |
2005 |
| Chronic Bronchitis |
Replidyne, Inc. |
Faropenem |
2005 |
| Hypertension |
Alteon |
Alagebrium |
2005 |
| Type II Diabetes |
Roche |
RO0730699 |
2005 |
| Pneumonia |
Advanced Life Sciences |
Clarithromycin |
2006 |
| COPD |
ALTANA Pharma, Inc. |
Roflumilast |
2006 |
| Hypertension |
Boehringer Ingelheim |
Micardis |
2006 |
| Atrial Fibrillation |
Sanofi-Aventis |
Dronedarone |
2006 |
| Atrial Fibrillation |
Boehringer Ingelheim |
Dabigatran |
2006 |
| Heartburn on NSAIDS |
Pfizer |
Celecoxib |
2006 |
| Heartburn |
PPD |
Prevacid |
2007 |
| Osteoarthritis of Knee & Hip |
Alpharma Pharmaceuticals |
Extended-Release Kadian |
2007 |
| Chronic Pain |
Alpharma Pharmaceuticals |
Extended-Release Kadian |
2007 |
Dr. Maxwell C. Eblaghie, PhD, CRCP
Chief Research Officer
Post-Doctoral Research Fellow, Albert Eye Research Institute Duke University, Durham, NC (2005-2007) Post-Doctoral Research Associate, Cell Biology, Duke University, Durham, NC (2003-2005)
PhD/Post-Doctoral Research Assistant, Cell and Developmental Biology, University of Dundee, Scotland (2000-2003)
Beth Merry, BSc, LPN, CRC
Research Study Coordinator
Michelle Lewis, LPN, CRC
Research Study Coordinator
Renea Yeagley, MA, CRC
Research Study Nurse/ PFT Technologist
Jamie Baughman, LPN, CRC
Research Study Nurse/ Recruitment Specialist
Patient Population in Blue Ridge, GA:
- 97.5% white (caucasian)
- 0.4% Hispanic/latino
- 0.2% black
- 0.3% asian
- 1.1% multi-racial
- 0.1% other
- 50.5% female
- 49.5% male
- 10.9% 0-9 years
- 12.5% 10-19 years
- 9.4% 20-29 years
- 12.9% 30-39 years
- 15.7% 40-49 years
- 15.2% 50-59 years
- 12.3% 60-69 years
- 7.8% 70-79 years
- 3.5% 80+ years
We use Central IRB
Interested sponsors and CROs can also contact Dr. Eblaghie
through an alternate email address:
maxwell.eblaghie@gmail.com.
Dr. Maxwell C. Eblaghie, PhD, CRCP
Chief Research Officer
River Birch Research Alliance, LLC
101 Riverstone Vista, Suite 201
Blue Ridge GA 30513
USA
Phone: 706-258-4112
Fax: 706-632-6006
EMail: meblaghie@riverstonemd.com
Web Site: http://www.riverbirchresearch.com
CenterWatch is listing the following trials that are actively recruiting patients at this center.
If you are interested in contacting this center to discuss placing a clinical
trial there, please complete and send the E-mail form below. A representative from
the research center will then follow up with you.